The "Manufacturing-as-a-Service" Milestone: How 2026 is...

added blog Health

2026-02-17 06:53:40 -

The "Manufacturing-as-a-Service" Milestone: How 2026 is Solving the Global Vector Bottleneck

By mid-2026, the industry has officially entered the era of "Modular Bioprocessing." This year, the focus is on the record-breaking success of all-in-one CDMO facilities that can switch between different AAV serotypes (like AAV9 or AAV2) in a matter of hours. This innovation is a primary driver for the market, as the Adeno-associated Virus Vector-based Gene Therapy Market has historically...

0 Comments 0 Shares 99 Views 0 Reviews